Cargando…

Practical outpatient pharmacotherapy for alcohol use disorder

Alcohol use disorder (AUD) is commonly encountered in clinical practice. A combination of psychosocial intervention and pharmacotherapy is the cornerstone of AUD treatment. Despite their efficacy, safety and cost-effectiveness, clinicians are reluctant to prescribe medications to treat individuals w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Youngjung, Hack, Laura M, Ahn, Elizabeth S, Kim, Jungjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804871/ https://www.ncbi.nlm.nih.gov/pubmed/29445407 http://dx.doi.org/10.7573/dic.212308

Ejemplares similares

Pharmacotherapy for Alcohol Use Disorders: Physicians’ Perceptions and Practices
por: Ponce Martinez, Caridad, et al.
Publicado: (2016)

Use of Pharmacotherapies in the Treatment of Alcohol Use Disorders and Opioid Dependence in Primary Care
por: Lee, Jinhee, et al.
Publicado: (2015)

Pharmacotherapy of Adolescent Alcohol and Other Drug Use Disorders
por: Solhkhah, Ramon, et al.
Publicado: (1998)

Improving access to alcohol use disorder pharmacotherapy and treatment in primary care settings
por: Hagedorn, Hildi, et al.
Publicado: (2015)

Pharmacotherapy for relapse prevention of alcohol use disorder in the Indian setting: A systematic review
por: Bharadwaj, Balaji, et al.
Publicado: (2018)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies
por: Florence, Luiza, et al.
Publicado: (2022)

Pharmacotherapy in patients with vasomotor disorders
por: Boerhout, C.K.M., et al.
Publicado: (2023)

Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions
por: Williams, Emily C., et al.
Publicado: (2019)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review
por: van Amsterdam, Jan, et al.
Publicado: (2022)

Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC
por: Hagedorn, Hildi J., et al.
Publicado: (2016)

Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study
por: Konrad, Geoffrey, et al.
Publicado: (2021)

Pharmacotherapy for Alcohol Dependence: Anticraving Medications for Relapse Prevention
por: Jung, Young-Chul, et al.
Publicado: (2006)

Review of Pharmacotherapy for Tinnitus
por: Kim, Sang Hoon, et al.
Publicado: (2021)

Intention-to-treat analyses and missing data approaches in pharmacotherapy trials for alcohol use disorders
por: Del Re, A C, et al.
Publicado: (2013)

Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration
por: Taylor, Emmeline, et al.
Publicado: (2019)

Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)
por: Joudrey, Paul J., et al.
Publicado: (2019)

The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use Disorder
por: Yuan, Jing, et al.
Publicado: (2022)

Machine learning prediction of dropping out of outpatients with alcohol use disorders
por: Park, So Jin, et al.
Publicado: (2021)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Pharmacotherapy treatment of stimulant use disorder
por: Liu, Mei T.
Publicado: (2021)

Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
por: Panin, Francesca, et al.
Publicado: (2019)

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review
por: Copeland, Jan, et al.
Publicado: (2016)

Pharmacotherapy for acid/peptic disorders.
por: Schubert, M. L.
Publicado: (1996)

Suicide Ideation among Outpatients with Alcohol Use Disorder
por: Hsu, Wen-Yu, et al.
Publicado: (2022)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus
por: Strupp, Michael, et al.
Publicado: (2011)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder
por: Lee, Yeon Jung, et al.
Publicado: (2014)

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders
por: Ng, J., et al.
Publicado: (2014)

Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
por: Prikhodko, Veronika A., et al.
Publicado: (2022)

The possible place for psychedelics in pharmacotherapy of mental disorders
por: Wojtas, Adam
Publicado: (2023)

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia
por: Ivanova, Anna, et al.
Publicado: (2009)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Efficient diagnosis of IDH-mutant gliomas: 1p/19qNET assesses 1p/19q codeletion status using weakly-supervised learning
por: Kim, Gi Jeong, et al.
Publicado: (2023)

Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010)

Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013)

Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013)

Current Long-Term Pharmacotherapies for the Management of Obesity
por: Kim, Bo-Yeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cnisf433d9dsu0ne08rm1okfec